Literature DB >> 7692638

Allostimulatory cells in fresh human blood: heterogeneity in antigen-presenting cell populations.

W Egner1, R Andreesen, D N Hart.   

Abstract

The relative ability of unmanipulated monocytes, B cells, and dendritic cells (DC) from peripheral blood to stimulate an allogeneic MLR has not been clearly established. We studied the allostimulatory ability of these cell types from minimally manipulated PBMC populations to exclude the induction of stimulatory properties by the complex isolation procedures commonly used to isolate blood DC. Highly purified cell populations were obtained from volunteer donors by immunolabeling PBMC with mAb directed against known lineage-associated markers and separating the positive and negative population on a FACS. These cells were used as stimulators in an allogeneic MLR. The major allostimulatory activity resides in the CD14, CD11b, and CD19 negative fractions. A mixture of antibodies to T, B, NK, monocyte, and FcRIII positive cells was then used to isolate a minor cell population that contained a markedly superstimulatory population of (CD3, CD14, CD16, CD19, and CD57) negative cells. We demonstrate that this activity is constitutive, and is not an artifact of the adherence and in vitro culture steps used in conventional DC purification procedures. We also show by rigorous depletion of the T cell responders that endogenous HLA class II positive cells in the responder population have little role in presenting processed allogeneic antigens during the primary MLR. Monocytes and B cells are stimulators of the allogeneic MLR, but are considerably less potent on a cell for cell basis than the putative DC population. Finally, because human blood and tonsil DC lack detectable CD43 by immunoperoxidase staining, in contrast to monocytes and activated B cells, we examined the ability of CD43 negative and positive cells to stimulate an allogeneic MLR. Similar allostimulatory activity for the human MLR was shown to reside in both the CD43 positive and negative fractions, suggesting that there may be some heterogeneity in the APC population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692638     DOI: 10.1097/00007890-199310000-00032

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells.

Authors:  J Almeida; C Bueno; M C Alguero; M L Sanchez; M C Cañizo; M E Fernandez; J M Vaquero; F J Laso; L Escribano; J F San Miguel; A Orfao
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Expression of the RelB transcription factor correlates with the activation of human dendritic cells.

Authors:  G J Clark; S Gunningham; A Troy; S Vuckovic; D N Hart
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

3.  Phenotypic characterization of five dendritic cell subsets in human tonsils.

Authors:  K L Summers; B D Hock; J L McKenzie; D N Hart
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.

Authors:  L J Zhou; T F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

5.  Adhesion molecules are upregulated on dendritic cells isolated from human blood.

Authors:  D A McCarthy; M G Macey; P A Bedford; S C Knight; D C Dumonde; K A Brown
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

6.  Identification of a novel dendritic cell surface antigen defined by carbohydrate specific CD24 antibody cross-reactivity.

Authors:  L A Williams; A D McLellan; K L Summers; R V Sorg; D B Fearnley; D N Hart
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

7.  The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations.

Authors:  W Egner; D N Hart
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

Authors:  M A Morse; L J Zhou; T F Tedder; H K Lyerly; C Smith
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

9.  Isolation and generation of human dendritic cells.

Authors:  Smita Nair; Gerald E Archer; Thomas F Tedder
Journal:  Curr Protoc Immunol       Date:  2012-11

10.  Dendritic cells in synovial fluid of chronic inflammatory arthritis lack CD80 surface expression.

Authors:  K L Summers; P B Daniel; J L O'Donnell; D N Hart
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.